Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein

Journal of Leukocyte Biology

Volumn 84, Issue 3, 2008, Pages 748-759

  Johnson, Teresa R ^a,c   Rothenberg, Marc E ^b   Graham, Barney S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Chemokines; Cytokines; Immunoregulation; Pathogenesis; Vaccine

Indexed keywords

EOTAXIN; INTERLEUKIN 5; RESPIRATORY SYNCYTIAL VIRUS VACCINE; THROMBOSPONDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOREGULATION; LOEFFLER PNEUMONIA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T CELL DEPLETION;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL11; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PULMONARY EOSINOPHILIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; VACCINIA VIRUS; VIRAL FUSION PROTEINS; VIRAL LOAD; WEIGHT LOSS;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 50849108564     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0907621     Document Type: Article

References (65)

1. Kim, H. W., Canchola, J. G., Brandt, C. D., Pyles, G., Chanock, R. M., Jensen, K., Parrott, R. H. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89, 422-434.
2. Kapikian, A. Z., Mitchell, R. H., Chanock, R. M., Shvedoff, R. A., Stewart, C. E. (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89, 405-421.
3. Prince, G. A., Jenson, A. B., Hemming, V. G., Murphy, B. R., Walsh, E. E., Horswood, R. L., Chanock, R. M. (1986) Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J. Virol. 57, 721-728.
4. Graham, B. S., Henderson, G. S., Tang, Y.-W., Lu, X., Neuzil, K. M., Colley, D. G. (1993) Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151, 2032-2040.
5. Tachibana, A., Kimura, H., Kato, M., Nako, Y., Kozawa, K., Morikawa, A. (2002) Respiratory syncytial virus enhances the expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor. Intervirology 45, 43-51.
6. Dimova-Yaneva, D., Russell, D., Main, M., Brooker, R. J., Helms, P. J. (2004) Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin. Exp. Allergy 34, 555-558.
7. Noah, T. L., Ivins, S. S., Murphy, P. M., Kazachkova, I., Moats-Staats, B., Henderson, F. W. (2002) Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin. Immunol. 104, 86-95.
8. Shirakawa, I., Deichmann, K. A., Izuhara, K., Mao, X. Q., Adra, C. N., Hopkin, J. M. (2000) Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol. Today 21, 60-64.
9. Ehlenfield, D. R., Cameron, K., Welliver, R. C. (2000) Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 105, 79-83.
10. McNamara, P. S., Smyth, R. L. (2002) The pathogenesis of respiratory syncytial virus disease in childhood. Br. Med. Bull. 61, 13-28.
11. Rosenberg, H. F., Domachowske, J. B. (2001) Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J. Leukoc. Biol. 70, 691-698.
12. Pifferi, M., Ragazzo, V., Caramella, D., Baldini, G. (2001) Eosinophil cationic protein in infants with respiratory syncytial virus bronchiolitis: predictive value for subsequent development of persistent wheezing. Pediatr. Pulmonol. 31, 419-424.
13. Tang, Y.-W., Graham, B. S. (1997) T cell source of Type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Invest. 99, 2183-2191.
14. Alwan, W. H., Kozlowska, W. J., Openshaw, P. J. M. (1994) Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179, 81-89.
15. Srikiatkhachorn, A., Braciale, T. J. (1997) Virus-specific, CD8+ T lymphocytes down regulate Th2 type cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186, 421-432.
16. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27, 3341-3349.
17. + T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 79, 2593-2601.
18. Kopf, M., Brombacher, F., Hodgkin, P. D., Ramsay, A. J., Milbourne, E. A., Dai, W. J., Ovington, K. S., Behm, C. A., Kohler, G., Young, I. G., et al. (1996) IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4, 15-24.
19. Resnick, M. B., Weller, P. F. (1993) Mechanisms of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8, 349-355.
20. Rothenberg, M. E., Ownbey, R., Mehlhop, P. D., Loiselle, P. M., van de Rijn, M., Bonventre, J. V., Oettgen, H. C., Leder, P., Luster, A. D. (1996) Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2, 334-348.
21. Mould, A. W., Matthaei, K. I., Young, I. G., Foster, P. S. (1997) Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99, 1064-1071.
22. Schweizer, R. C., Welmers, B. A. C., Raaijmakers, J. A. M., Zanen, P., Lammers, J.-W. J., Koenderman, L. (1994) RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 83, 3697-3704.
23. Rothenberg, M. E., MacLean, J. A., Pearlman, E., Luster, A. D., Leder, P. (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185, 785-790.
24. Gonzalo, J. A., Jia, G. Q., Aguirre, V., Friend, D., Coyle, A. J., Jenkins, N. A., Lin, G. S., Katz, H., Lichtman, A., Copeland, N., et al. (1996) Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 4, 1-4.
25. Bandeira-Melo, C., Herbst, A., Weller, P. F. (2001) Eotaxins: contributing to the diversity of eosinophil recruitment and activation. Am. J. Respir. Cell Mol. Biol. 24, 653-657.
26. Badewa, A. P., Hudson, C. E., Heiman, A. S. (2002) Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation. Exp. Biol. Med. 227, 645-651.
27. MacLean, J. A., Ownbey, R., Luster, A. D. (1996) T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophilia. J. Exp. Med. 184, 1461-1469.
28. Hogan, S. P., Mishra, A., Brandt, E. B., Royalty, M. P., Pope, S. M., Zimmerman, N., Foster, P. S., Rothenberg, M. E. (2001) A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat. Immunol. 2, 353-360.
29. Watanabe, K., Jose, P. J., Rankin, S. M. (2002) Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages. J. Immunol. 168, 1911-1918.
30. Rothenberg, M. E., Luster, A. D., Leder, P. (1995) Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA 92, 8960-8964.
31. Yang, M., Hogan, S. P., Mahalingam, S., Pope, S. M., Zimmerman, N., Fulkerson, P., Dent, L. A., Young, I. G., Matthaei, K. I., Rothenberg, M. E., et al. (2003) Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J. Allergy Clin. Immunol. 112, 935-943.
32. Meyer-Hoffert, U., Lezcano-Meza, D., Bartels, J., Montes-Vizuet, A. R., Schroder, J. M., Teran, L. M. (2003) Th2- and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and Gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3, and MCP-4) chemokines in human airway epithelial cells. Int. Arch. Allergy Immunol. 131, 264-271.
33. Boehme, S. A., Lio, F. M., Sikora, L., Pandit, T. S., Lavrador, K., Rao, S. P., Sriramarao, P. (2004) Serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin. J. Immunol. 173, 3599-3603.
34. Fukuda, K., Yamada, N., Fujitsu, Y., Kumagai, N., Nishida, T. (2002) Inhibition of eotaxin expression in human corneal fibroblasts by interferon-γ. Int. Arch. Allergy Immunol. 129, 138-144.
35. Matsukura, S., Kokubu, F., Kuga, H., Kawaguchi, M., Ieki, K., Odaka, M., Suzuki, S., Watanabe, S., Takeuchi, H., Adachi, M., et al. (2003) Differential regulation of eotaxin expression by IFN-γ in airway epithelial cells. J. Allergy Clin. Immunol. 111, 1337-1344.
36. Johnson, T. R., Johnson, J. E., Roberts, S. R., Wertz, G. W., Parker, R. A., Graham, B. S. (1998) Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72, 2871-2880.
37. Bembridge, G. P., Garcia-Beato, R., Lopez, J. A., Melero, J. A., Taylor, G. (1998) Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. J. Immunol. 161, 2473-2480.
38. Johnson, T. R., Graham, B. S. (1999) Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J. Virol. 73, 8485-8495.
39. Johnson, T. R., Parker, R. A., Johnson, J. E., Graham, B. S. (2003) IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. J. Immunol. 170, 2037-2045.
40. Hancock, G. E., Speelman, D. J., Heers, K., Bortell, E., Smith, J., Cosco, C. (1996) Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J. Virol. 70, 7783-7791.
41. Graham, B. S., Bunton, L. A., Wright, P. F., Karzon, D. T. (1991) Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88, 1026-1033.
42. Johnson, T. R., Fischer, J. E., Graham, B. S. (2001) Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. J. Gen. Virol. 82, 2107-2116.
43. Zlotnik, A., Yoshie, O., Nomiyama, H. (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 7, 243.1-243.11.
44. Loetscher, P., Pellegrino, A., Gong, J.-H., Mattioli, I., Loetscher, M., Bardi, G., Baggiolini, M., Clark-Lewis, I. (2001) The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10 are natural antagonists for CCR3. J. Biol. Chem. 276, 2986-2991.
45. Hussell, T., Georgiou, A., Sparer, T. E., Matthews, S., Pala, P., Openshaw, P. J. M. (1998) Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J. Immunol. 161, 6215-6222.
46. Neuzil, K. M., Johnson, J. E., Tang, Y.-W., Prieels, J.-P., Slaoui, M., Gar, N., Graham, B. S. (1997) Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine. Vaccine 15, 525-532.
47. Taylor, G., Thomas, L. H., Stott, E. J. (1989) Effect of vaccination on cell populations in lung washes from calves after infection with respiratory syncytial virus. Res. Vet. Sci. 47, 231-235.
48. Garofalo, R., Kimpen, J. L. L., Welliver, R. C., Ogra, P. L. (1992) Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120, 28-32.
49. Johnson, J. E., Gonzales, R. A., Olson, S. J., Wright, P. F., Graham, B. S. (2007) The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20, 108-119.
50. McNamara, P. S., Ritson, P., Selby, A., Hart, C. A., Smyth, R. L. (2003) Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch. Dis. Child. 88, 922-926.
51. Pope, S. M., Brandt, E. B., Mishra, A., Hogan, S. P., Zimmerman, N., Matthaei, K. I., Foster, P. S., Rothenberg, M. E. (2001) IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 108, 594-601.
52. Miller, A. L., Strieter, R. M., Gruber, A. D., Ho, S. B., Lukacs, N. W. (2003) CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J. Immunol. 170, 3348-3356.
53. Stevenson, C. S., Coote, K., Webster, R., Johnston, H., Atherton, H. C., Nicholls, A., Sugar, R., Jackson, A., Press, N. J., Brown, Z., et al. (2005) Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L514-L522.
54. Sigurs, N., Bjarnason, R., Sigurbergsson, F. (1994) Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Paediatr. 83, 1151-1155.
55. Tang, Y.-W., Graham, B. S. (1994) Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94, 1953-1958.
56. Connors, M., Giese, N. A., Kulkarni, A. B., Firestone, C.-Y., Morse, I., Murphy, B. R. (1994) Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68, 5321-5325.
57. Wang, J., Palmer, K., Lotvall, J., Milan, S., Lei, X.-F., Matthaei, K. I., Gauldie, J., Inman, M. D., Jordana, M., Xing, Z. (1998) Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J. Clin. Invest. 102, 1132-1141.
58. Pope, S. M., Zimmerman, N., Stringer, K. F., Karow, M. L., Rothenberg, M. E. (2005) The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J. Immunol. 175, 5341-5350.
59. Eum, S. Y., Maghni, K., Tolloczko, B., Eidelman, D. H., Martin, J. G. (2005) IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L576-L584.
60. Matthews, S. P., Tregoning, J. S., Coyle, A. J., Hussell, T., Openshaw, P. J. (2005) Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection. J. Virol. 79, 2050-2057.
61. Varga, S. M., Wang, X., Welsh, R. M., Braciale, T. J. (2001) Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4+ T cells. Immunity 15, 637-646.
62. Rothenberg, M. E. (1999) Eotaxin: an essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21, 291-295.
63. Zimmermann, N., Hogan, S. P., Mishra, A., Brandt, E. B., Bodette, T. R., Pope, S. M., Finkelman, F. D., Rothenberg, M. E. (2005) Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J. Immunol. 165, 5839-5846.
64. Branwell, M. E., Tolley, N. S., Williams, T. J., Mitchell, T. J. (2002) Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids. Cytokine 17, 317-323.
65. Domachowske, J. B., Bonville, C. A., Dyer, K. D., Easton, A. J., Rosenberg, H. F. (2000) Pulmonary eosinophilia and production of MIP-1α are prominent responses to infection with pneumonia virus of mice. Cell. Immunol. 200, 98-104.